We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Improved Neurosurgery for Movement Disorders

By HospiMedica staff writers
Posted on 05 Dec 2005
A system that morphs brain images can considerably simplify a neurosurgical method called deep brain stimulation (DBS) that is gaining acceptance in the treatment of movement disorders, including stiffness, tremor, rigidity, and slowed movement, caused by neurologic disorders such as Parkinson's disease, dystonia, multiple sclerosis, and obsessive-compulsive disease.

DBS is a very long, complex, and costly procedure, which involves implanting electrodes deep in the brain. More...
To improve the procedure, electrical engineers and neuroscientists at Vanderbilt University (Nashville, TN, USA) have designed a pilot guidance system that automates the most complex part of the procedure: identifying the correct location to insert the electrodes. To function properly, the electrodes must pass through small nuclei deep in the brain that are about the size of a pea and are not visible in brain scans or to the naked eye.

"The biggest problem with the procedure is that the surgeons cannot see the structure where they have to put the electrode and, as a result, they must spend a considerable amount of time searching for it,” said Dr. Benoit Dawant, professor of electrical engineering, computer engineering, and radiologic sciences at Vanderbilt University.

The computer-aided guidance system compensates for disparities in the three-dimensional (3D) brain structure of each patient, something very difficult for surgeons to do by themselves. It reduces operating times by increasing the chances that the surgeons start searching very close to the target. To develop the system, Dr. Dawant's team started with the brain magnetic resonance imaging (MRI) scans of 21 post-operative DBS patients. Next, the researchers developed an advanced, multi-dimensional technique for morphing one brain scan into another and used this to combine all 21 brain scans to form a reference brain atlas.

Once they developed the atlas, the investigators started testing how well it predicts the invisible target's location in new patients. They did this by morphing the reference brain, with its cluster of electrode positions, onto a scan of the patient's brain. They then selected a point in the center of the cluster as their predicted target location. In six implantations, Dr. Dawant's team provided predictions to colleagues when they were planning the procedure. In four cases, the surgeons used the system's prediction and found the target area in the first pass.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.